{"name":"Adienne SA","slug":"adienne-sa","ticker":"","exchange":"","domain":"","description":"Adienne SA is a pharmaceutical company with a focus on developing and commercializing treatments in specific therapeutic areas. The company has one drug in its portfolio, which is a conventional second-line treatment that has been discontinued. Limited financial and operational data are available.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQMUdxY21DNUNuekxLT3BZZWFNTmt4SHBRQmVyNFNKX204a1NZYTFpNGMtZl96dG5HQWV2QUJBMXdlMEFULXZocFdRbWs1ZlFXUmp3UmRXaVQ5UkxuOTdjNjg0YUNMaXc2NDBGVXhTSnUwUnlMU19fTjhKblNBNzBoWGpRZ1U?oc=5","date":"2025-09-10","type":"pipeline","source":"drugstorenews.com","summary":"Amneal launches multichambered Tepadina bag for oncology - drugstorenews.com","headline":"Amneal launches multichambered Tepadina bag for oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNd1RKR2x0UzdNdEdJREN1NE5aLTloSWp0OGpyejFJZ1U5T0hIS2pORkFnTHZ5Q1dfY0w1RTZOZ3B6QUhLbHhBSFREMXp5Mml0a0gyQmdmXzVRSEoxYzg1VGFROWtZT2E3czk3M0k5TE9ualVvbUpoOEs1MmgxeUg2b2pfeHRleFRVS05KMVN3Nm52NlFKd3lvMk91NDZMQQ?oc=5","date":"2021-03-16","type":"pipeline","source":"The Moscow Times","summary":"Explainer: Sputnik V’s Road to the European Market - The Moscow Times","headline":"Explainer: Sputnik V’s Road to the European Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPcFR6NmRacm9pNE43Zjh6a2M2S0VxWURqMWRLbFJyeWJaTVVOcS1zRlVOb2VEeWRDWllIQmVPTW4xV3haa3hZcnNPa1J0NF9IQnUtWkkxZWdYZ1FLM2VHY3pCNEtORkFseE1fUGxvYW1NUjAxNTI1a0hqRVdJZG0wdU1ERXIxQzJfM3NobVhLQUZRdWZPV3J6UjdTMHNndw?oc=5","date":"2021-03-16","type":"pipeline","source":"The Moscow Times","summary":"Russia Threatens to Block Twitter Within 30 Days - The Moscow Times","headline":"Russia Threatens to Block Twitter Within 30 Days","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNcXBYRzBmZXpONnc0b0YtR1B2Q0c0SkFtREZnczhCdHl1VG1zaFNxNWxQbWhoc295TVRjVHRmV0JoUGxROWMzaVdhQ2NWMUZqWDZhV2w0Q3N6Ty1yRmdiZllsbVVPT2lnbjhHMlNyZDlFcDRuSXd5NGRqa09CQi1TNjFpbloyNFc5clhBR2ZZbXZLVEtDZjNveEdMOE5KS09OZXNfVF9VY1U5bU9fTVcyV2w0QldOV1k3?oc=5","date":"2016-09-12","type":"trial","source":"Fierce Biotech","summary":"Adienne plans Swiss IPO to fund pivotal GvHD trial and advance orphan drug pipeline - Fierce Biotech","headline":"Adienne plans Swiss IPO to fund pivotal GvHD trial and advance orphan drug pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}